# Observational ovarian cancer studies recruiting: 151 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 151 trials that are observational for ovarian cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational ovarian cancer studies: 151 rows for $7.55, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/ovarian-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 151
- Recruiting or not yet: 151
- Read on: November 19, 2026

## Trials

The 25 newest of 151, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07940049 | CovaRisk: Validating a Digital Tool for Ovarian Cancer Risk Assessment and Referral | Benha University | Observational | Not yet recruiting | Cancer Ovaries, Ovarian Mass, Borderline Ovarian Cancer | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940049) |
| October 27, 2026 | NCT07896421 | Real-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and... | AbbVie | Observational | Recruiting | Platinum-Resistant FRα-Positive Ovarian Cancer, Platinum-Resistant FRα-Positive Fallopian Tube Cancer... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896421) |
| October 22, 2026 | NCT07889843 | Folate Receptor Alpha (FRα) Expression and Heterogeneity in Epithelial Ovarian Cancer | Hellenic Cooperative Oncology Group | Observational | Recruiting | High Grade Serous Ovarian Cancer, Folate Receptor Alpha Positive | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889843) |
| October 20, 2026 | NCT07883798 | Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Cervical Cancer, Gynecologic Cancer, Endometrial Cancer, Uterine Cancer, Uterine Sarcoma, Ovarian Cancer, Fallopian... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883798) |
| October 20, 2026 | NCT07883551 | AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery | Catharina Ziekenhuis Eindhoven | Observational | Not yet recruiting | Ovarian Cancer, Ovarian Tumor, Borderline Ovarian Tumor | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883551) |
| September 11, 2026 | NCT07814872 | A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment | Harvard Medical School (HMS and HSDM) | Observational | Not yet recruiting | Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic... | 30,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814872) |
| September 8, 2026 | NCT07808320 | HERCULES: Ultrasound-Based Liver Involvement Classification in Ovarian Cancer | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Ovarian Cancer, Recurrent Ovarian Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808320) |
| August 28, 2026 | NCT07793201 | Machine Learning Algorithms Incorporating Radiomic Ultrasound Features | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Adnexal Masses | 12,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793201) |
| August 24, 2026 | NCT07783022 | Real-World Study of Niraparib in First-Line Maintenance Therapy for Advanced Epithelial Ovarian Cancer | Fudan University | Observational | Recruiting | Ovarian Cancer | 1,920 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783022) |
| August 24, 2026 | NCT07782164 | Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) | Amsterdam UMC, location VUmc | Observational | Recruiting | Colorectal Carcinoma, Renal Cancer, Bladder Cancer, Cervical Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer... | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782164) |
| August 18, 2026 | NCT07771400 | Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients | Latin American Cooperative Oncology Group | Observational | Recruiting | Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Fallopian Tube Cancer Stage III... | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771400) |
| August 11, 2026 | NCT07757711 | Implementation of New Models of Ovarian Carcinoma Resistant to Therapy | Mario Negri Institute for Pharmacological Research | Observational | Not yet recruiting | Ovarian Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07757711) |
| July 29, 2026 | NCT07732686 | Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry | University of Oklahoma | Observational | Not yet recruiting | Pancreas Cancer, Hepatocellular Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Cancer, Colon... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732686) |
| July 21, 2026 | NCT07716800 | Predictors of Cognitive Decline and Delirium in Older Women With Ovarian Cancer | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Ovarian Cancer, Cognitive Decline, Delirium | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07716800) |
| July 14, 2026 | NCT07702721 | Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Gynecologic Cancer, Cervical Cancer, Endometrial Cancer, Ovary Cancer, Vulvar Cancer | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702721) |
| July 9, 2026 | NCT07693894 | Innovative Ovarian Cancer Biomarker Assays | National and Kapodistrian University of Athens | Observational | Recruiting | Ovarian Cancer | 2,080 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07693894) |
| July 8, 2026 | NCT07690332 | A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα） | Sponsor not shown (see the record) | Observational | Not yet recruiting | Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07690332) |
| June 26, 2026 | NCT07670962 | Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy | Asan Medical Center | Observational | Not yet recruiting | Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Ovarian Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670962) |
| June 24, 2026 | NCT07667192 | Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Recurrent Gynecologic Cancer, Recurrent Uterine Cancer, Recurrent Cervical Cancer, Recurrent Vaginal Cancer, Recurrent... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667192) |
| June 12, 2026 | NCT07645716 | Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic Oncology | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Ovarian Neoplasms, Uterine Neoplasms | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645716) |
| May 18, 2026 | NCT07593833 | Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection | Tongji Hospital | Observational | Not yet recruiting | Ovarian Neoplasms, Ovarian Cancer, Early Detection of Cancer | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593833) |
| May 14, 2026 | NCT07586449 | A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian Cancer | Zhejiang Cancer Hospital | Observational | Not yet recruiting | Ovarian Cancer (OvCa) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07586449) |
| April 23, 2026 | NCT07546578 | Setting Up ctDNA Analysis on Archived Plasma Samples | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Ovarian Cancer, Liquid Biopsy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07546578) |
| April 20, 2026 | NCT07540403 | Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinoma | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Ovarian Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540403) |
| April 20, 2026 | NCT07539844 | Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental... | AbbVie | Observational | Recruiting | Ovarian Cancer | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07539844) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 18 |
| Fudan University | 4 |
| University Health Network, Toronto | 3 |
| Tongji Hospital | 3 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 3 |
| University Hospital, Strasbourg, France | 2 |
| McGill University | 2 |
| Abramson Cancer Center at Penn Medicine | 2 |
| National Cancer Institute, Naples | 2 |
| Imperial College London | 2 |
| Institut Paoli-Calmettes | 2 |
| Azienda USL Reggio Emilia - IRCCS | 2 |
| Hospices Civils de Lyon | 2 |
| Affidea Nu-med Center of Oncological DIagnostics and Therapy | 2 |
| Zhejiang Cancer Hospital | 2 |
| National Cancer Institute (NCI) | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Peking University Third Hospital | 2 |
| Medical University of Vienna | 2 |
| Centro di Riferimento Oncologico - Aviano | 2 |
| University of Aarhus | 2 |
| Asan Medical Center | 2 |
| Assiut University | 2 |
| Latin American Cooperative Oncology Group | 1 |
| Seoul National University Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 33 |
| Italy | 28 |
| China | 17 |
| France | 9 |
| United Kingdom | 7 |
| Canada | 7 |
| Germany | 6 |
| Belgium | 5 |
| South Korea | 4 |
| Taiwan | 4 |
| Argentina | 3 |
| Czechia | 3 |
| Netherlands | 3 |
| Austria | 3 |
| Denmark | 3 |
| Brazil | 2 |
| Colombia | 2 |
| Mexico | 2 |
| Poland | 2 |
| Spain | 2 |
| Greece | 2 |
| Japan | 1 |
| India | 1 |
| Finland | 1 |
| Norway | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Cuban restaurants in the United States](https://specstream.ai/data/businesses/cuban-restaurants/united-states)
- [Gastroenterology practices in the United States](https://specstream.ai/data/businesses/gastroenterology-practices/united-states)
- [Lighting fixtures and equipment companies in the United States](https://specstream.ai/data/businesses/lighting-fixtures-and-equipment-companies/united-states)
- [Plastic and reconstructive surgery practices in the United States](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/united-states)
- [Stone and masonry companies in the United States](https://specstream.ai/data/businesses/stone-and-masonry-companies/united-states)
- [Aircraft parts suppliers in the United States](https://specstream.ai/data/businesses/aircraft-parts-suppliers/united-states)
